Asymptomatic hyperparathyroidism - Need for multicentre studies

Clinical Endocrinology

Volumn 68, Issue 2, 2008, Pages 155-164

  Mihai, Radu ^a   Wass, John A H ^b   Sadler, Gregory P ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIMIMETIC AGENT; CALCIUM; CINACALCET; ESTROGEN; ETIDRONIC ACID; PLACEBO; RALOXIFENE;

BONE DENSITY; CARDIOVASCULAR RISK; CLINICAL TRIAL; ESTROGEN THERAPY; FOLLOW UP; GLUCOSE INTOLERANCE; HEALTH CARE COST; HUMAN; HYPERPARATHYROIDISM; LIPID METABOLISM; OSTEOLYSIS; OSTEOPOROSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; THYROID SURGERY;

GLUCOSE INTOLERANCE; HUMANS; HYPERPARATHYROIDISM; MULTICENTER STUDIES AS TOPIC; OSTEOPOROSIS; PARATHYROIDECTOMY; QUALITY OF LIFE;

EID: 38049130293     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02970.x     Document Type: Review

References (92)

1. Melton, L.J. 3rd. (1991) Epidemiology of primary hyperparathyroidism. Journal of Bone and Mineral Research, 6 (Suppl. 2 S25 S30.
2. Adami, S., Marcocci, C. Gatti, D. (2002) Epidemiology of primary hyperparathyroidism in Europe. Journal of Bone and Mineral Research, 17 (Suppl. 2 N18 N23.
3. Jorde, R., Bonaa, K.H. Sundsfjord, J. (2000) Primary hyperparathyroidism detected in a health screening. The Tromso study. Journal of Clinical Epidemiology, 53, 1164 1169.
4. Heath, H. 3rd., Hodgson, S.F. Kennedy M.A. (1980) Primary hyperparathyroidism. Incidence, morbidity, and potential economic impact in a community. New England Journal of Medicine, 302, 189 193.
5. Melton, L.J. 3rd 2002) The epidemiology of primary hyperparathyroidism in North America. Journal of Bone and Mineral Research, 17 (Suppl. 2 N12 N17.
6. Bilezikian, J.P., Potts, J.T. Jr., Fuleihan Gel, H., Kleerekoper, M., Neer, R., Peacock, M., Rastad, J., Silverberg, S.J., Udelsman, R. Wells, S.A. (2002) Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. Journal of Clinical Endocrinology and Metabolism, 87, 5353 5361.
7. Mahadevia, P.J., Sosa, J.A., Levine, M.A., Zeiger, M.A. Powe, N.R. (2003) Clinical management of primary hyperparathyroidism and thresholds for surgical referral: a national study examining concordance between practice patterns and consensus panel recommendations. Endocrine Practice, 9, 494 503.
8. Sosa, J.A., Powe, N.R., Levine, M.A., Udelsman, R. Zeiger, M.A. (1998) Profile of a clinical practice: thresholds for surgery and surgical outcomes for patients with primary hyperparathyroidism: a national survey of endocrine surgeons. Journal of Clinical Endocrinology and Metabolism, 83, 2658 2665.
9. Kouvaraki, M.A., Greer, M., Sharma, S., Beery, D., Armand, R., Lee, J.E., Evans, D.B. Perrier, N.D. (2006) Indications for operative intervention in patients with asymptomatic primary hyperparathyroidism: practice patterns of endocrine surgery. Surgery, 139, 527 534.
10. Silverberg, S.J., Shane, E., Jacobs, T.P., Siris, E. Bilezikian, J.P. (1999) A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. New England Journal of Medicine, 341, 1249 1255.
11. Ambrogini, E., Cianferotti, L., Vignali, E., Cetani, F., Viccica, G., Picone, A., Miccoli, P., Pinchera, A. Marcocci, C. (2006) Asymptomatic primary hyperparathyroidism: preliminary results of a prospective randomized study on the effect of parathyroidectomy. Endocrine Abstracts, 11, P30.
12. McDermott, M.T., Perloff, J.J. Kidd, G.S. (1994) Effects of mild asymptomatic primary hyperparathyroidism on bone mass in women with and without estrogen replacement therapy. Journal of Bone and Mineral Research, 9, 509 514.
13. Jorde, R. Sundsfjord, J. (2000) Bone mineral density and blood pressure in patients with asymptomatic hyperparathyroidism. The Tromso Study. Journal of Internal Medicine, 247, 325 330.
14. Grey, A.B., Stapleton, J.P., Evans, M.C. Reid, I.R. (1996) Accelerated bone loss in post-menopausal women with mild primary hyperparathyroidism. Clinical Endocrinology, 44, 697 702.
15. Christiansen, P., Steiniche, T., Brixen, K., Hessov, I., Melsen, F., Heickendorff, L. Mosekilde, L. (1999) Primary hyperparathyroidism: short-term changes in bone remodeling and bone mineral density following parathyroidectomy. Bone, 25, 237 244.
16. Fuliehan, G.E., Moore, F. Jr., LeBoff, M.S., Hurwitz, S., Gundberg, C.M., Angell, J. Scott, J. (1999) Longitudinal changes in bone density in hyperparathyroidism. Journal of Clinical Densitometry, 2, 153 162.
17. Nomura, R., Sugimoto, T., Tsukamoto, T., Yamauchi, M., Sowa, H., Chen, Q., Yamaguchi, T., Kobayashi, A. Chihara, K. (2004) Marked and sustained increase in bone mineral density after parathyroidectomy in patients with primary hyperparathyroidism; a six-year longitudinal study with or without parathyroidectomy in a Japanese population. Clinical Endocrinology, 60, 335 342.
18. Hagstrom, E., Lundgren, E., Mallmin, H., Rastad, J. Hellman, P. (2006) Positive effect of parathyroidectomy on bone mineral density in mild asymptomatic primary hyperparathyroidism. Journal of Internal Medicine, 259, 191 198.
19. Elvius, M., Lagrelius, A., Nygren, A., Alveryd, A., Christensson, T.A. Nordenstrom, J. (1995) Seventeen year follow-up study of bone mass in patients with mild asymptomatic hyperparathyroidism some of whom were operated on. European Journal of Surgery, 161, 863 869.
20. Bollerslev, J., Jansson, S., Mollerup, C.L., Nordenström, J., Lundgren, E., Tørring, O., Varhaug, J.-E., Baranowski, M., Aanderud, S., Franco, C., Freyschuss, B., Isaksen, G.A., Ueland, T. Rosen, T. on behalf on the SIPH Study Group (2007) Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. Journal of Clinical Endocrinology and Metabolism, 92, 1687 1692.
21. Silverberg, S.J., Shane, E., de la Cruz, L., Dempster, D.W., Feldman, F., Seldin, D., Jacobs, T.P., Siris, E.S., Cafferty, M., Parisien, M.V., Lindsay, R., Clemens, T.L. Bilezikian, J.P. (1989) Skeletal disease in primary hyperparathyroidism. Journal of Bone and Mineral Research, 4, 283 291.
22. Grey, A.B., Cundy, T.F. Reid, J.R. (1994) Continuous combined oestrogen/progestin therapy is well tolerated and increases bone mineral density at the hip and spine in post-menopausal osteoporosis. Clinical Endocrinology, 40, 671 677.
23. Garton, M., Martin, J., Stewart, A., Krukowski, Z., Matheson, N., Robins, S., Loveridge, N. Reid, D. (1995) Changes in bone mass and metabolism after surgery for primary hyperparathyroidism. Clinical Endocrinology, 42, 493 500.
24. Potts, J.T. (1991) Proceedings of the NIH consensus development conference on diagnosis and management of asymptomatic primary hyperparathyroidism. Journal of Bone and Mineral Research, 6, 9 13.
25. Kenny, A.M., MacGillivray, D.C., Pilbeam, C.C., Crombie, H.D. Raisz, L.G. (1995) Fracture incidence in postmenopausal women with primary hyperparathyroidism. Surgery, 118, 109 114.
26. Kochersberger, G., Buckley, N.J., Leight, G.S., Martinez, S., Studenski, S., Vogler, J. Lyles, K.W. (1987) What is the clinical significance of bone loss in primary parathyroidism? Archives of Internal Medicine, 47, 1951 1953.
27. Khosla, S. Melton, J. (2002) Fracture risk in primary hyperparathyroidism. Journal of Bone and Mineral Research, 17 (Suppl. 2 N103 N117.
28. Larsson, K., Ljunghall, S., Krusemo, U.B., Naessen, T., Lindh, E. Persson, I. (1993) The risk of hip fractures in patients with primary hyperparathyroidism: a population-based cohort study with a follow-up of 19 years. Journal of Internal Medicine, 234, 585 593.
29. Wilson, R.J., Rao, S., Ellis, B., Kleerekoper, M. Parfitt, A.M. (1998) Mild asymptomatic primary hyperparathyroidism is not a risk factor for vertebral fractures. Annals of Internal Medicine, 109, 959 962.
30. Melton, L.J. III., Atkinson, E.J., O'Fallon, W.M. Heath, H. III. 1992) Risk of age-related fractures in patients with primary hyperparathyroidism. Archives of Internal Medicine, 152, 2269 2273.
31. Vestergaard, P. Mosekilde, L. (2004) Parathyroid surgery is associated with a decreased risk of hip and upper arm fractures in primary hyperparathyroidism: a controlled cohort study. Journal of Internal Medicine, 255, 108 114.
32. Vestergaard, P. Mosekilde, L. (2003) Fractures in patients with primary hyperparathyroidism: nationwide follow-up study of 1201 patients. World Journal of Surgery, 27, 343 349.
33. VanderWalde, L.H., Liu, I.L., O'Connell, T.X. Haigh, P.I. (2006) The effect of parathyroidectomy on bone fracture risk in patients with primary hyperparathyroidism. Archives of Surgery, 141, 885 891.
34. Andersson, P., Rydberg, E. Willenheimer, R. (2004) Primary hyperparathyroidism and heart disease - a review. European Heart Journal, 25, 1776 1787.
35. Rubin, M.R., Maurer, M.S., McMahon, D.J., Bilezikian, J.P. Silverberg, S.J. (2005) Arterial stiffness in mild primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 90, 3326 3330.
36. Piovesan, A., Molineri, N., Casasso, F., Emmolo, I., Ugliengo, G., Cesario, F. Borretta, G. (1999) Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clinical Endocrinology, 50, 321 328.
37. Almqvist, E.G., Bondeson, A.G., Bondeson, L., Nissborg, A., Smedgard, P. Svensson, S.E. (2002) Cardiac dysfunction in mild primary hyperparathyroidism assessed by radionuclide angiography and echocardiography before and after parathyroidectomy. Surgery, 132, 1126 1132.
38. Garcia de la Torre, N., Wass, J.A. Turner, H.E. (2003) Parathyroid adenomas and cardiovascular risk. Endocrine-Related Cancer, 10, 309 322.
39. Nilsson, I.L., Aberg, J., Rastad, J. Lind, L. (2005) Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism. Surgery, 137, 632 638.
40. Nilsson, I.L., Aberg, J., Rastad, J. Lind, L. (2000) Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism - effects of parathyroidectomy. Surgery, 128, 895 902.
41. Chiu, K.C., Chuang, L.M., Lee, N.P., Ryu, J.M., McGullam, J.L., Tsai, G.P. Saad, M.F. (2000) Insulin sensitivity is inversely correlated with plasma intact parathyroid hormone level. Metabolism, 49, 1501 1505.
42. Procopio, M. Borretta, G. (2003) Derangement of glucose metabolism in hyperparathyroidism. Journal of Endocrinological Investigation, 26, 1136 1142.
43. Procopio, M., Magro, G., Cesario, F., Piovesan, A., Pia, A., Molineri, N. Borretta, G. (2002) The oral glucose tolerance test reveals a high frequency of both impaired glucose tolerance and undiagnosed type 2 diabetes mellitus in primary hyperparathyroidism. Diabetic Medicine, 19, 958 961.
44. Ayturk, S., Gursoy, A., Bascil Tutuncu, N., Ertugrul, D.T. Guvener Demirag, N. (2006) Changes in insulin sensitivity and glucose and bone metabolism over time in patients with asymptomatic primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 91, 4260 4263.
45. Richards, M.L. Thompson, N.W. (1999) Diabetes mellitus with hyperparathyroidism: another indication for parathyroidectomy? Surgery, 126, 1160 1166.
46. Khaleeli, A.A., Johnson, J.N. Taylor, W.H. (2006) Prevalence of glucose intolerance in primary hyperparathyroidism and the benefit of parathyroidectomy. Diabetes and Metabolic Research Review, 23, 43 48.
47. Hagstrom, E., Lundgren, E., Lithell, H., Berglund, L., Ljunghall, S., Hellman, P. Rastad, J. (2002) Normalized dyslipidaemia after parathyroidectomy in mild primary hyperparathyroidism: population-based study over five years. Clinical Endocrinology, 56, 253 260.
48. Hagstrom, E., Lundgren, E., Rastad, J. Hellman, P. (2006) Metabolic abnormalities in patients with normocalcemic hyperparathyroidism detected at a population-based screening. European Journal of Endocrinology, 155, 33 139.
49. Bolland, M.J., Grey, A.B., Gamble, G.D. Reid, I.R. (2005) Association between primary hyperparathyroidism and increased body weight: a meta-analysis. Journal of Clinical Endocrinology and Metabolism, 90, 1525 1530.
50. Leifsson, B.G. Ahren B. (1996) Serum calcium and survival in a large health screening program. Journal of Clinical Endocrinology and Metabolism, 81, 2149 2153.
51. Lundgren, E., Lind, L., Palmer, M., Jakobsson, S., Ljunghall, S. Rastad, J. (2001) Increased cardiovascular mortality and normalized serum calcium in patients with mild hypercalcemia followed up for 25 years. Surgery, 130, 978 985.
52. Hedback, G., Oden, A. Tisell, L.E. (1991) The influence of surgery on the risk of death in patients with primary hyperparathyroidism. World Journal of Surgery, 15, 399 405.
53. Ogard, C.G., Engholm, G., Almdal, T.P. Vestergaard, H. (2004) Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977-1993 in Denmark. World Journal of Surgery, 28, 108 111.
54. Nilsson, I.L., Yin, L., Lundgren, E., Rastad, J. Ekbom, A. (2002) Clinical presentation of primary hyperparathyroidism in Europe - nationwide cohort analysis on mortality from nonmalignant causes. Journal of Bone and Mineral Research, 17 (Suppl. 2 N68 N74.
55. Nilsson, I.L., Wadsten, C., Brandt, L., Rastad, J. Ekbom, A. (2004) Mortality in sporadic primary hyperparathyroidism: nationwide cohort study of multiple parathyroid gland disease. Surgery, 136, 981 987.
56. Soreide, J.A., van Heerden, J.A., Grant, C.S., Yau Lo, C., Schleck, C. Ilstrup, D.M. (1997) Survival after surgical treatment for primary hyperparathyroidism. Surgery, 122, 1117 1123.
57. Coker, L.H., Rorie, K., Cantley, L., Kirkland, K., Stump, D., Burbank, N., Tembreull, T., Williamson, J. Perrier, N. (2005) Primary hyperparathyroidism, cognition, and health-related quality of life. Annals of Surgery, 242, 642 650.
58. Roman, S.A., Sosa, J.A., Mayes, L., Desmond, E., Boudourakis, L., Lin, R., Snyder, P.J., Holt, E. Udelsman, R. (2005) Parathyroidectomy improves neurocognitive deficits in patients with primary hyperparathyroidism. Surgery, 138, 1121 1128.
59. Dotzenrath, C.M., Kaetsch, A.K., Pfingsten, H., Cupisti, K., Weyerbrock, N., Vossough, A., Verde, P.E. Ohmann, C. (2006) Neuropsychiatric and cognitive changes after surgery for primary hyperparathyroidism. World Journal of Surgery, 30, 680 685.
60. Prager, G., Kalaschek, A., Kaczirek, K., Passler, C., Scheuba, C., Sonneck, G. Niederle, B. (2002) Parathyroidectomy improves concentration and retentiveness in patients with primary hyperparathyroidism. Surgery, 132, 930 935.
61. Chiang, C.Y., Andrewes, D.G., Anderson, D., Devere, M., Schweitzer, I. Zajac, J.D. (2005) A controlled, prospective study of neuropsychological outcomes post parathyroidectomy in primary hyperparathyroid patients. Clinical Endocrinology, 62, 99 104.
62. Burney, R.E., Jones, K.R., Peterson, M., Christy, B. Thompson, N.W. (1998) Surgical correction of primary hyperparathyroidism improves quality of life. Surgery, 124, 987 991.
63. Quiros, R.M., Alef, M.J., Wilhelm, S.M., Djuricin, G., Loviscek, K. Prinz, R.A. (2003) Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery, 134, 675 681.
64. Sheldon, D.G., Lee, F.T., Neil, N.J. Ryan, J.A. Jr. (2002) Surgical treatment of hyperparathyroidism improves health-related quality of life. Archives of Surgery, 137, 1022 1026.
65. Caillard, C., Sebag, F., Mathonnet, M., Gibelin, H., Brunaud, L., Loudot, C., Kraimps, J.L., Hamy, A., Bresler, L. Charbonnel, B. (2007) Prospective evaluation of quality of life (SF-36v2) and nonspecific symptoms before and after cure of primary hyperparathyroidism (1-year follow-up). Surgery, 141, 153 159.
66. Burney, R.E., Jones, K.R., Christy, B. Thompson, N.W. (1999) Health status improvement after surgical correction of primary hyperparathyroidism in patients with high and low preoperative calcium levels. Surgery, 125, 608 614.
67. Eigelberger, M.S., Cheah, W.K., Ituarte, P.H., Streja, L., Duh, Q.Y. Clark, O.H. (2004) NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited? Annals of Surgery, 239, 528 535.
68. Sywak, M.S., Knowlton, S.T., Pasieka, J.L., Parsons, L.L. Jones, J. (2002) Do the National Institutes of Health consensus guidelines for parathyroidectomy predict symptom severity and surgical outcome in patients with primary hyperparathyroidism? Surgery, 132, 1013 1019.
69. Kebebew, E., Duh, Q.Y. Clark, O.H. (2003) Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a plea for early surgical referral. Archives of Surgery, 138, 867 871.
70. Talpos, G.B., Bone, H.G. 3rd, Kleerekoper, M., Phillips, E.R., Alam, M., Honasoge, M., Divine, G.W. Rao, D.S. (2000) Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery, 128, 1013 1020.
71. Walgenbach, S., Hommel, G. Junginger, T. (2000) Outcome after surgery for primary hyperparathyroidism: ten-year prospective follow-up study. World Journal of Surgery, 24, 564 569.
72. Hasse, C., Sitter, H., Bachmann, S., Zielke, A., Koller, M., Nies, C., Lorenz, W. Rothmund, M. (2000) How asymptomatic is asymptomatic primary hyperparathyroidism? Experimental and Clinical Endocrinology and Diabetes, 108, 265 274.
73. Lundgren, E., Ljunghall, S., Akerstrom, G., Hetta, J., Mallmin, H. Rastad, J. (1998) Case-control study on symptoms and signs of 'asymptomatic' primary hyperparathyroidism. Surgery, 124, 980 985.
74. Lundgren, E., Szabo, E., Ljunghall, S., Bergstrom, R., Holmberg, L. Rastad, J. (1998) Population based case-control study of sick leave in postmenopausal women before diagnosis of hyperparathyroidism. British Medical Journal, 317, 848 851.
75. Stefaniak, J., Locker, R., Silverberg, M. & Bilezikian, M. (1997) Optimal dietary calcium intake in primary hyperparathyroidism. American Journal of Medicine, 102, 543 550.
76. Marcus, R. (2002) The role of estrogens and related compounds in the management of primary hyperparathyroidism. Journal of Bone and Mineral Research, 17 (Suppl. 2 N146 N149.
77. Grey, A.B., Stapleton, J.P., Evans, M.C., Tatnell, M.A. Reid, I.R. (1996) Effect of hormone replacement therapy on bone mineral density in postmenopausal women with mild primary hyperparathyroidism. Annals of Internal Medicine, 125, 360 368.
78. Rubin, M.A. Lee, K.H., McMahon, D.J. Silverberg, S.J. (2003) Raloxifene lowers serum calcium and markers of bone turnover in postmenopausal women with primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 88, 1174 1178.
79. Rodan, G.A. (2002) Bisphosphonates and primary hyperparathyroidism. Journal of Bone and Mineral Research, 17 (Suppl. 2 N150 N153.
80. Parker, C.R., Blackwell, P.J., Fairbairn, K.J. Hosking, D.J. (2002) Alendronate in the treatment of primary hyperparathyroid-related osteoporosis: a 2-year study. Journal of Clinical Endocrinology and Metabolism, 87, 4482 4489.
81. Chow, C.C., Chan, W.B., Li, J.K.Y., Chan, N.N., Chan, M.H.M., Ko, G.T.C., Lo, K.W. Cockram, C.S. (2003) Oral alendronate increases bone mineral density in postmenopausal women with primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 88, 581 587.
82. Khan, A.A., Bilezikian, J.P., Kung, A.W.C., Ahmed, M.M., Dubois, S.J., Ho, A.Y.Y., Schussheim, D., Rubin, M.R., Shaikh, A.M., Silverberg, S.J., Standish, T.I., Syed, Z. Syed, Z.A. (2004) Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial. Journal of Clinical Endocrinology and Metabolism, 89, 3319 3325.
83. Rossini, M., Gatti, D., Isaia, G., Sartori, L., Braga, V. Adami, S. (2001) Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism. Journal of Bone and Mineral Research, 16, 113 119.
84. Horiuchi, T., Onouchi, T., Inoue, J., Shionoiri, A., Hosoi, T. Orimo, H. (2002) A strategy for the management of elderly women with primary hyperparathyroidism: a comparison of etidronate therapy with parathyroidectomy. Gerontology, 48, 103 108.
85. Peacock, M., Bilezikian, J.P., Klassen, P.S., Guo, M.D., Turner, S.A. Shoback, D. (2005) Cinacalcet hydrochloride maintains long-term normocalcemia in patients with primary hyperparathyroidism. Journal of Clinical Endocrinology and Metabolism, 90, 135 141.
86. Russell, C.F., Laird, J.D. Ferguson, W.R. (1990) Scan-directed unilateral cervical exploration for parathyroid adenoma: a legitimate approach? World Journal of Surgery, 14, 406 409.
87. Sidhu, S., Neill, A.K. Russell, C.F. (2003) Long-term outcome of unilateral parathyroid exploration for primary hyperparathyroidism due to presumed solitary adenoma. World Journal of Surgery, 27, 339 342.
88. Mihai, R., Palazzo, F.F., Gleeson, F.V. Sadler, G.P. (2007) Minimally invasive parathyroidectomy without intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism. British Journal of Surgery, 94, 42 47.
89. Agarwal, G., Barraclough, B.H., Robinson, B.G., Reeve, T.S. Delbridge, L.W. (2002) Minimally invasive parathyroidectomy using the 'focused' lateral approach. I. Results of the first 100 consecutive cases. ANZ Journal of Surgery, 72, 100 104.
90. Gallagher, S.F., Denham, D.W., Murr, M.M. Norman, J.G. (2003) The impact of minimally invasive parathyroidectomy on the way endocrinologists treat primary hyperparathyroidism. Surgery, 134, 910 917.
91. Zanocco, K., Angelos, P. Sturgeon, C. (2006) Cost-effectiveness analysis of parathyroidectomy for asymptomatic primary hyperparathyroidism. Surgery, 140, 874 882.
92. Sejean, K., Calmus, S., Durand-Zaleski, I., Bonnichon, P., Thomopoulos, P., Cormier, C., Legmann, P., Richard, B., Bertagna, X.Y. Vidal-Trecan, G.M. (2005) Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis. European Journal of Endocrinology, 153, 915 927.